RenovoRx (RNXT) Interest Coverage Ratio (2020 - 2026)
RenovoRx (RNXT) posted Interest Coverage Ratio of 266.85 for Q1 2026, up 99.33% sequentially from 40022.73 in Q4 2025, and down 2602.78% YoY from 10.66 in Q1 2025.
RenovoRx (RNXT) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
RenovoRx has reported Interest Coverage Ratio for 7 years, with the latest figure at 266.85 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 2602.78% year-over-year to 266.85 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 989.92 (down 2587.23% YoY) and the FY2025 annual result came in at 0.63, up 3.33% from the prior year.
- Interest Coverage Ratio rose to 266.85 in Q1 2026 per RNXT's latest filing, from 40022.73 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.16 in Q4 2024 and troughed at 40022.73 in Q4 2025.
- A 5-year average of 2374.28 and a median of 3.72 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio jumped 91.63% in 2024, then sank 25521991.74% in 2025.
- Over 5 years, Interest Coverage Ratio stood at 2.34 in 2022, then gained by 19.84% to 1.87 in 2023, then surged by 91.63% to 0.16 in 2024, then tumbled by 25521991.74% to 40022.73 in 2025, then soared by 99.33% to 266.85 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 266.85, 40022.73, and 3.72 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | RenovoRx | 62.20 Mn | 62.20 Mn | 766,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.88 |
| Mar 31, 2026 | -266.85 |
| Dec 31, 2025 | -40,022.73 |
| Sep 30, 2025 | -3.72 |
| Jun 30, 2025 | -2.71 |
| Mar 31, 2025 | -9.87 |
| Dec 31, 2024 | -0.16 |
| Sep 30, 2024 | -14.50 |
| Jun 30, 2024 | -10.46 |
| Mar 31, 2024 | -4.53 |
| Dec 31, 2023 | -1.87 |
| Sep 30, 2023 | -8.62 |
| Jun 30, 2023 | -3.97 |
| Mar 31, 2023 | -1.53 |
| Dec 31, 2022 | -2.34 |
| Sep 30, 2022 | -3.01 |
| Jun 30, 2022 | -3.68 |
| Mar 31, 2022 | -2.30 |
| Dec 31, 2021 | 3.21 |
| Sep 30, 2021 | -0.37 |